GRI Bio GRI Cash Flow Statement (2020-2026)

NASDAQ GRI
$1.52 +0.06 (+4.45%)
As of: Oct 21, 2026 · 11:11 AM EDT
Reported Financials

GRI Bio Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

GRI Bio reported cash from operations of -$1.45M and free cash flow of -$1.45M for the quarter ended Jun 2026, up 54.3% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-1.26M-3.10M-0.30M-0.30M-0.35M-2.27M-2.15M-6.75M-2.14M-2.00M-1.89M-2.25M-2.12M-1.95M-3.05M-2.89M-3.36M-2.66M-2.00M-1.64M
Depreciation and DepletionDep. & Depletion
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.02M0.02M0.02M-0.02M0.05M0.17M1.16M1.16M
Depreciation & Amortization (CF)Dep. & Amort.
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Share-based CompensationStock Comp.
0.13M0.19M0.18M-0.18M0.03M0.01M0.01M0.33M0.04M0.04M0.04M0.04M0.04M0.22M0.04M0.47M0.07M0.03M0.03M
Gains from Investment SecuritiesGains Investment
Other non-cash itemsOther Non-Cash
0.01M0.27M-0.76M0.34M0.01M0.08M-0.03M-0.19M0.01M-0.02M0.01M0.01M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Account PayablesChange Payables
-0.40M0.42M0.32M-0.24M0.00M0.82M0.41M3.77M0.68M-2.70M-0.74M0.34M0.25M-0.24M0.33M0.04M0.02M0.27M-1.51M0.22M
Change in Accured ExpensesChange Accured Exp.
0.04M0.70M-0.23M0.63M0.18M0.11M-0.04M1.19M-0.05M-0.98M-0.17M-0.08M-0.39M0.16M0.56M-0.29M0.43M-0.64M-0.32M0.10M
Change in Other Operating AssetsOther Assets Change
-0.17M-0.16M-0.04M0.05M0.00M0.03M-0.03M0.78M0.09M-0.29M-0.56M0.19M0.05M0.01M-0.20M0.06M-0.13M0.01M-0.11M0.16M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M0.14M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Other Working Capital ChangesOther WC Changes
0.17M0.16M0.04M-0.05M-0.01M-0.04M0.01M-0.79M-0.10M0.28M0.55M-0.05M-0.06M-0.02M0.19M-0.08M0.12M-0.03M0.09M-0.17M
Cash from OperationsCash from Ops.
-1.29M-1.58M-2.29M2.17M-0.13M-0.84M-0.58M-1.54M-1.31M-5.56M-2.20M-2.14M-2.27M-2.00M-1.74M-3.17M-2.31M-2.97M-3.69M-1.45M
Investing Activities
Capital ExpendituresCapex
0.00M
Change in Property, Plant and EquipmentChange in PP&E
0.00M
Purchase of InvestmentsInvestments Purchased
3.27M0.58M0.15M
Sale and Maturity of InvestmentsInvestments Sold
1.15M1.37M1.48M0.42M
Cash from Investing ActivitiesCash from Investing
-3.27M-0.58M1.15M-1.15M0.00M-0.01M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.13M1.38M1.25M
Long-Term Debt RepaymentsLT Debt Repayment
0.02M0.02M0.02M0.02M-0.03M0.11M
Non-Current Debt
-0.02M-0.02M-0.02M-0.02M0.16M1.27M1.25M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.02M-0.02M-0.02M-0.02M0.16M1.27M1.25M
Change in Capital Stock
Common Stock IssuedStock Issued
0.01M5.50M-5.50M0.00M0.76M0.94M-5.94M6.82M1.40M
Net Shares Issued and RepurchasedNet Shares Issued
0.01M5.50M-5.50M0.00M0.76M0.94M-5.94M6.82M1.40M
Net Equity Issued and RepurchasedNet Equity Issued
0.01M5.50M-5.50M0.00M0.76M0.94M-5.94M6.82M1.40M
Other financing activitiesOther financing
-0.12M-0.22M-3.44M0.94M-1.01M-0.56M-0.37M-0.10M-0.01M-0.93M-0.37M-0.85M-0.32M-0.05M
Cash from Financing ActivitiesCash from Financing
-0.02M-0.02M-0.02M0.06M0.22M0.75M1.03M5.89M3.88M4.49M4.40M0.66M2.28M-0.01M5.01M1.25M7.15M6.50M1.35M
Additional items
Change in Cash
-4.58M-2.18M-1.16M1.08M0.10M-0.10M0.45M4.34M-1.31M-1.68M2.28M2.26M-1.61M0.28M-1.75M1.84M-1.07M4.17M2.82M-0.10M
Ending Cash Balance
5.88M0.09M2.54M0.01M0.10M0.01M0.46M4.80M3.49M1.81M4.09M6.35M4.75M5.03M3.28M5.12M4.06M8.23M11.05M10.95M
Free Cash FlowFCF
-1.29M-1.58M-2.29M2.17M-0.13M-0.85M-0.58M-1.54M-1.31M-5.56M-2.20M-2.14M-2.27M-2.00M-1.74M-3.17M-2.31M-2.97M-3.69M-1.45M
Net Cash FlowNCF
-4.58M-2.18M-1.16M1.08M0.10M-0.10M0.45M4.34M-1.31M-1.68M2.28M2.26M-1.61M0.28M-1.75M1.84M-1.07M4.18M2.82M-0.10M

GRI Bio Cash Flow Statement API

Pull GRI Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GRI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY